Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-05

Clinical Trial Update: Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 study evaluating fecal microbiota transplantation as a potential treatment for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: COMPLETED